International Clinical Trials Day provided the chance to recognise the many people contributing to our life-changing clinical trials. Two key events were staged to mark the day, including a presentation in the Kolling auditorium from leading clinical trial investigators, and a public display within Royal North Shore Hospital.  More than 300 trials are underway across Northern Sydney including .....
Read more

Check out our latest newsletter Researchers target sleep for muscle pain relief Landmark clinical trial to improve lung cancer treatment Pioneering Muscle Map project receives funding support Travel awards for emerging research leaders And much more:  Click here:
Read more

Royal North Shore Hospital’s Associate Professor Brendon Neuen will establish an international consortium to support those with both heart and kidney disease. The nephrologist and Director of Kidney Trials will lead the collaboration after being awarded close to $500,000 from NSW Health through a program to drive groundbreaking projects in heart disease. The grant will support the establishment of .....
Read more

An exciting partnership between AGRF Ltd (Australian Genome Research Facility) and the University of Sydney and the Kolling Institute will help strengthen genomic capabilities. The partnership will see a specialised team and cutting-edge technology located within the institute to progress research in this increasingly crucial field. As Australia’s largest provider of genomic services, AGRF supports.....
Read more

We would like to thank everyone involved in the 2024 Kolling Institute Symposium. During the event, a diverse collection of researchers detailed the latest progress with their ground-breaking work into kidney and heart disease treatments, bone and muscle conditions, rare cancers, and neurological challenges. There was a focus too on the innovative work to develop a unique wellbeing index. Researche.....
Read more

In the heart of the Kolling Institute, a world-renowned research centre, a raft of clinical trials is driving the future of healthcare. “Clinical trials are intrinsic to research,” says Professor James Elliott, Academic Director of the institute. “They help us test something so that we can better inform care for patients with various conditions who come to our hospitals for treatment.” The Kolling .....
Read more

Our Kolling Institute Year in Review profiles our innovative and life-changing research across the Kolling Institute. Our researchers are driving investigations into some of the most challenging health conditions from heart and kidney disease to musculoskeletal conditions, chronic pain, cancer and neurodegenerative disorders. Our teams have continued to increase their research impact, while forging.....
Read more

A culture of collaboration is a key part of the Kolling Institute’s research impact, and just one example of this is a joint project to reduce the devastating impact of vascular disease linked to diabetes. The study has brought together research experts from endocrinology and cardiology to curb the number of lower limb amputations due to peripheral arterial disease. Alarmingly, an estimated eight p.....
Read more

Here's a snapshot of our latest research at the Kolling Institute and the impact it's having across the community, from new national guidelines for physios helping those with life-changing spinal cord injuries to a new approach for those with debilitating chronic pain. There's a focus too on our researchers reducing the physical toll of spaceflight and the latest care for osteoarthritis.  Flip.....
Read more

Less than two years after a breast cancer diagnosis, Professor Gemma Figtree has completed the prestigious Boston Marathon while raising significant funds for cancer research. Gemma crossed the finish line in a sub four hour time as part of the talented team running for the internationally renowned Dana Farber Cancer Institute. Gemma ran her first marathon just after completing six months of chemot.....
Read more